30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Adhera Therapeutics Inc (ATRX)

Track

Stock chart
Ticker: ATRX Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Trieu Vuong
Chairman of the Board
1 purchase — total 3,900 USD
Buy 9 Jun 2017
Value US$1,972,482.08 | Price 283.23 | Shares 54,055
Buy 8 Jun 2017
Value US$2,738,229.48 | Price 420.94 | Shares 2,816
Buy 7 Jun 2017
Value US$950.00 | Price 0.38 | Shares 2,500
Buy 7 Apr 2017
Value US$9,562.50 | Price 0.43 | Shares 22,500
Buy 6 Apr 2017
Value US$4,368.00 | Price 0.34 | Shares 13,000
Buy 5 Apr 2017
Value US$30,435.60 | Price 0.31 | Shares 97,550
Buy 6 Feb 2017
Value US$249,999.72 | Price 0.29 | Shares 862,068
Buy 16 Apr 2014
Value US$19,998.52 | Price 0.76 | Shares 26,300
Sale 10 Feb 2014
Value US$15,270.00 | Price 1.02 | Shares 15,000
Sale 7 Feb 2014
Value US$59,413.00 | Price 1.01 | Shares 59,000
Sale 6 Feb 2014
Value US$32,304.91 | Price 0.95 | Shares 34,041
Sale 4 Oct 2013
Value US$8,333.50 | Price 0.24 | Shares 35,000
Sale 3 Oct 2013
Value US$16,334.50 | Price 0.25 | Shares 65,000
Sale 26 Jan 2011
Value US$4,573.80 | Price 1.21 | Shares 3,780
Sale 26 Jan 2011
Value US$2,467.20 | Price 1.20 | Shares 2,056
Sale 26 Jan 2011
Value US$12,768.70 | Price 1.19 | Shares 10,730
Sale 26 Jan 2011
Value US$19,805.12 | Price 1.18 | Shares 16,784
Sale 26 Jan 2011
Value US$22,873.50 | Price 1.17 | Shares 19,550
Sale 26 Jan 2011
Value US$12,412.00 | Price 1.16 | Shares 10,700
Sale 26 Jan 2011
Value US$2,185.00 | Price 1.15 | Shares 1,900
Sale 26 Jan 2011
Value US$1,482.00 | Price 1.14 | Shares 1,300
Sale 26 Jan 2011
Value US$2,938.00 | Price 1.13 | Shares 2,600
Sale 26 Jan 2011
Value US$1,344.00 | Price 1.12 | Shares 1,200
Sale 26 Jan 2011
Value US$1,998.00 | Price 1.11 | Shares 1,800
Sale 26 Jan 2011
Value US$440.00 | Price 1.10 | Shares 400
Sale 26 Jan 2011
Value US$763.00 | Price 1.09 | Shares 700
Sale 26 Jan 2011
Value US$1,080.00 | Price 1.08 | Shares 1,000
Sale 25 Jan 2011
Value US$840.00 | Price 1.20 | Shares 700
Sale 25 Jan 2011
Value US$472.00 | Price 1.18 | Shares 400
Sale 25 Jan 2011
Value US$783.90 | Price 1.17 | Shares 670
Sale 25 Jan 2011
Value US$1,774.80 | Price 1.16 | Shares 1,530
Sale 25 Jan 2011
Value US$22,080.00 | Price 1.15 | Shares 19,200
Sale 25 Jan 2011
Value US$10,265.70 | Price 1.14 | Shares 9,005
Sale 25 Jan 2011
Value US$5,763.00 | Price 1.13 | Shares 5,100
Sale 25 Jan 2011
Value US$16,912.00 | Price 1.12 | Shares 15,100
Sale 25 Jan 2011
Value US$669.00 | Price 1.12 | Shares 600
Sale 25 Jan 2011
Value US$29,082.00 | Price 1.11 | Shares 26,200
Sale 25 Jan 2011
Value US$13,200.00 | Price 1.10 | Shares 12,000
Sale 25 Jan 2011
Value US$2,725.00 | Price 1.09 | Shares 2,500
Sale 24 Jan 2011
Value US$7,942.20 | Price 1.22 | Shares 6,510
Sale 24 Jan 2011
Value US$121.25 | Price 1.21 | Shares 100
Sale 24 Jan 2011
Value US$28,798.00 | Price 1.21 | Shares 23,800
Sale 24 Jan 2011
Value US$723.00 | Price 1.21 | Shares 600
Sale 24 Jan 2011
Value US$481.00 | Price 1.20 | Shares 400
Sale 24 Jan 2011
Value US$21,488.40 | Price 1.20 | Shares 17,907
Sale 24 Jan 2011
Value US$4,620.77 | Price 1.19 | Shares 3,883
Sale 24 Jan 2011
Value US$16,756.00 | Price 1.18 | Shares 14,200
Sale 24 Jan 2011
Value US$3,510.00 | Price 1.17 | Shares 3,000
Sale 24 Jan 2011
Value US$2,436.00 | Price 1.16 | Shares 2,100
Sale 24 Jan 2011
Value US$345.00 | Price 1.15 | Shares 300
Sale 21 Jan 2011
Value US$260.00 | Price 1.30 | Shares 200
Sale 21 Jan 2011
Value US$387.00 | Price 1.29 | Shares 300
Sale 21 Jan 2011
Value US$1,152.00 | Price 1.28 | Shares 900
Sale 21 Jan 2011
Value US$7,537.45 | Price 1.27 | Shares 5,935
Sale 21 Jan 2011
Value US$28,809.90 | Price 1.26 | Shares 22,865
Sale 21 Jan 2011
Value US$42,750.00 | Price 1.25 | Shares 34,200
Sale 21 Jan 2011
Value US$6,076.00 | Price 1.24 | Shares 4,900
Sale 21 Jan 2011
Value US$246.00 | Price 1.23 | Shares 200
Sale 20 Jan 2011
Value US$1,500.00 | Price 1.50 | Shares 1,000
Sale 20 Jan 2011
Value US$149.00 | Price 1.49 | Shares 100
Sale 20 Jan 2011
Value US$6,570.00 | Price 1.46 | Shares 4,500
Sale 20 Jan 2011
Value US$6,292.00 | Price 1.43 | Shares 4,400
Sale 20 Jan 2011
Value US$3,976.00 | Price 1.42 | Shares 2,800
Sale 20 Jan 2011
Value US$2,115.00 | Price 1.41 | Shares 1,500
Sale 20 Jan 2011
Value US$7,280.00 | Price 1.40 | Shares 5,200
Sale 20 Jan 2011
Value US$6,255.00 | Price 1.39 | Shares 4,500
Sale 20 Jan 2011
Value US$8,682.96 | Price 1.38 | Shares 6,292
Sale 20 Jan 2011
Value US$284.96 | Price 1.37 | Shares 208
Sale 20 Jan 2011
Value US$3,645.00 | Price 1.35 | Shares 2,700
Sale 20 Jan 2011
Value US$2,735.81 | Price 1.33 | Shares 2,057
Sale 20 Jan 2011
Value US$2,564.76 | Price 1.32 | Shares 1,943
Sale 20 Jan 2011
Value US$3,275.00 | Price 1.31 | Shares 2,500
Sale 20 Jan 2011
Value US$2,600.00 | Price 1.30 | Shares 2,000
Sale 20 Jan 2011
Value US$258.00 | Price 1.29 | Shares 200
Sale 20 Jan 2011
Value US$1,270.00 | Price 1.27 | Shares 1,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2017-06-12 2017-06-09 B Purchase Trieu Vuong

Chairman of the Board

Executive Director Large shareholder
54,055 -40.2%
283.23
US$1,972,482 		54,055 -40.2% 283.23 US$1,972,482
2017-06-08 2017-06-08 B Purchase Trieu Vuong

Chairman of the Board

Executive Director Large shareholder
2,816 +1.8%
420.94
US$2,738,229 		2,816 +1.8% 420.94 US$2,738,229
2017-06-08 2017-06-07 B Purchase Trieu Vuong

Chairman of the Board

Executive Director Large shareholder
82,570 -8.0%
148.92
US$2,614,908 		82,570 -8.0% 148.92 US$2,614,908
2017-04-07 2017-04-07 B Purchase Ramelli Joseph W.

Chief Executive Officer
22,500 +5.4%
0.43
US$9,562 		22,500 +5.4% 0.43 US$9,562
2017-04-07 2017-04-06 B Purchase Ramelli Joseph W.

Chief Executive Officer
13,000 +3.2%
0.34
US$4,368 		13,000 +3.2% 0.34 US$4,368
2017-04-05 2017-04-05 B Purchase Ramelli Joseph W.

Chief Executive Officer
97,550 +31.7%
0.31
US$30,436 		97,550 +31.7% 0.31 US$30,436
2017-02-08 2017-02-06 B Purchase Trieu Vuong

Chairman of the Board

Executive Director Large shareholder
862,068 +inf%
0.29
US$250,000 		862,068 +inf% 0.29 US$250,000
2014-04-18 2014-04-16 B Purchase Ramelli Joseph W. Non-Executive Director
26,300 +14.5%
0.76
US$19,999 		26,300 +14.5% 0.76 US$19,999
2014-02-10 2014-02-10 S Sale Pryor Cashman LLP Large shareholder
15,000 -0.9%
1.02
US$15,270 		15,000 -0.9% 1.02 US$15,270
2014-02-10 2014-02-07 S Sale Pryor Cashman LLP Large shareholder
59,000 -3.5%
1.01
US$59,413 		59,000 -3.5% 1.01 US$59,413
2014-02-10 2014-02-06 S Sale Pryor Cashman LLP Large shareholder
34,041 -2.0%
0.95
US$32,305 		34,041 -2.0% 0.95 US$32,305
2013-10-04 2013-10-04 S Sale Pryor Cashman LLP Large shareholder
35,000 -2.0%
0.24
US$8,334 		35,000 -2.0% 0.24 US$8,334
2013-10-04 2013-10-03 S Sale Pryor Cashman LLP Large shareholder
65,000 -3.6%
0.25
US$16,334 		65,000 -3.6% 0.25 US$16,334
2011-01-27 2011-01-26 S Sale Novartis Bioventures Ltd Large shareholder
3,780 -0.2%
1.21
US$4,574 		3,780 -0.2% 1.21 US$4,574
2011-01-27 2011-01-26 S Sale Novartis Bioventures Ltd Large shareholder
2,056 -0.1%
1.20
US$2,467 		2,056 -0.1% 1.20 US$2,467
2011-01-27 2011-01-26 S Sale Novartis Bioventures Ltd Large shareholder
10,730 -0.4%
1.19
US$12,769 		10,730 -0.4% 1.19 US$12,769
2011-01-27 2011-01-26 S Sale Novartis Bioventures Ltd Large shareholder
16,784 -0.7%
1.18
US$19,805 		16,784 -0.7% 1.18 US$19,805
2011-01-27 2011-01-26 S Sale Novartis Bioventures Ltd Large shareholder
19,550 -0.8%
1.17
US$22,874 		19,550 -0.8% 1.17 US$22,874
2011-01-27 2011-01-26 S Sale Novartis Bioventures Ltd Large shareholder
10,700 -0.4%
1.16
US$12,412 		10,700 -0.4% 1.16 US$12,412
2011-01-27 2011-01-26 S Sale Novartis Bioventures Ltd Large shareholder
1,900 -0.1%
1.15
US$2,185 		1,900 -0.1% 1.15 US$2,185
2011-01-27 2011-01-26 S Sale Novartis Bioventures Ltd Large shareholder
1,300 -0.1%
1.14
US$1,482 		1,300 -0.1% 1.14 US$1,482
2011-01-27 2011-01-26 S Sale Novartis Bioventures Ltd Large shareholder
2,600 -0.1%
1.13
US$2,938 		2,600 -0.1% 1.13 US$2,938
2011-01-27 2011-01-26 S Sale Novartis Bioventures Ltd Large shareholder
1,200 -0.0%
1.12
US$1,344 		1,200 -0.0% 1.12 US$1,344
2011-01-27 2011-01-26 S Sale Novartis Bioventures Ltd Large shareholder
1,800 -0.1%
1.11
US$1,998 		1,800 -0.1% 1.11 US$1,998
2011-01-27 2011-01-26 S Sale Novartis Bioventures Ltd Large shareholder
400 -0.0%
1.10
US$440 		400 -0.0% 1.10 US$440
2011-01-27 2011-01-26 S Sale Novartis Bioventures Ltd Large shareholder
700 -0.0%
1.09
US$763 		700 -0.0% 1.09 US$763
2011-01-27 2011-01-26 S Sale Novartis Bioventures Ltd Large shareholder
1,000 -0.0%
1.08
US$1,080 		1,000 -0.0% 1.08 US$1,080
2011-01-27 2011-01-25 S Sale Novartis Bioventures Ltd Large shareholder
700 -0.0%
1.20
US$840 		700 -0.0% 1.20 US$840
2011-01-27 2011-01-25 S Sale Novartis Bioventures Ltd Large shareholder
400 -0.0%
1.18
US$472 		400 -0.0% 1.18 US$472
2011-01-27 2011-01-25 S Sale Novartis Bioventures Ltd Large shareholder
670 -0.0%
1.17
US$784 		670 -0.0% 1.17 US$784
2011-01-27 2011-01-25 S Sale Novartis Bioventures Ltd Large shareholder
1,530 -0.1%
1.16
US$1,775 		1,530 -0.1% 1.16 US$1,775
2011-01-27 2011-01-25 S Sale Novartis Bioventures Ltd Large shareholder
19,200 -0.7%
1.15
US$22,080 		19,200 -0.7% 1.15 US$22,080
2011-01-27 2011-01-25 S Sale Novartis Bioventures Ltd Large shareholder
9,005 -0.3%
1.14
US$10,266 		9,005 -0.3% 1.14 US$10,266
2011-01-27 2011-01-25 S Sale Novartis Bioventures Ltd Large shareholder
5,100 -0.2%
1.13
US$5,763 		5,100 -0.2% 1.13 US$5,763
2011-01-27 2011-01-25 S Sale Novartis Bioventures Ltd Large shareholder
15,100 -0.6%
1.12
US$16,912 		15,100 -0.6% 1.12 US$16,912
2011-01-27 2011-01-25 S Sale Novartis Bioventures Ltd Large shareholder
600 -0.0%
1.12
US$669 		600 -0.0% 1.12 US$669
2011-01-27 2011-01-25 S Sale Novartis Bioventures Ltd Large shareholder
26,200 -1.0%
1.11
US$29,082 		26,200 -1.0% 1.11 US$29,082
2011-01-27 2011-01-25 S Sale Novartis Bioventures Ltd Large shareholder
12,000 -0.5%
1.10
US$13,200 		12,000 -0.5% 1.10 US$13,200
2011-01-27 2011-01-25 S Sale Novartis Bioventures Ltd Large shareholder
2,500 -0.1%
1.09
US$2,725 		2,500 -0.1% 1.09 US$2,725
2011-01-25 2011-01-24 S Sale Novartis Bioventures Ltd Large shareholder
6,510 -0.2%
1.22
US$7,942 		6,510 -0.2% 1.22 US$7,942
2011-01-25 2011-01-24 S Sale Novartis Bioventures Ltd Large shareholder
100 -0.0%
1.21
US$121 		100 -0.0% 1.21 US$121
2011-01-25 2011-01-24 S Sale Novartis Bioventures Ltd Large shareholder
23,800 -0.9%
1.21
US$28,798 		23,800 -0.9% 1.21 US$28,798
2011-01-25 2011-01-24 S Sale Novartis Bioventures Ltd Large shareholder
600 -0.0%
1.21
US$723 		600 -0.0% 1.21 US$723
2011-01-25 2011-01-24 S Sale Novartis Bioventures Ltd Large shareholder
400 -0.0%
1.20
US$481 		400 -0.0% 1.20 US$481
2011-01-25 2011-01-24 S Sale Novartis Bioventures Ltd Large shareholder
17,907 -0.7%
1.20
US$21,488 		17,907 -0.7% 1.20 US$21,488
2011-01-25 2011-01-24 S Sale Novartis Bioventures Ltd Large shareholder
3,883 -0.1%
1.19
US$4,621 		3,883 -0.1% 1.19 US$4,621
2011-01-25 2011-01-24 S Sale Novartis Bioventures Ltd Large shareholder
14,200 -0.5%
1.18
US$16,756 		14,200 -0.5% 1.18 US$16,756
2011-01-25 2011-01-24 S Sale Novartis Bioventures Ltd Large shareholder
3,000 -0.1%
1.17
US$3,510 		3,000 -0.1% 1.17 US$3,510
2011-01-25 2011-01-24 S Sale Novartis Bioventures Ltd Large shareholder
2,100 -0.1%
1.16
US$2,436 		2,100 -0.1% 1.16 US$2,436
2011-01-25 2011-01-24 S Sale Novartis Bioventures Ltd Large shareholder
300 -0.0%
1.15
US$345 		300 -0.0% 1.15 US$345
2011-01-25 2011-01-21 S Sale Novartis Bioventures Ltd Large shareholder
200 -0.0%
1.30
US$260 		200 -0.0% 1.30 US$260
2011-01-25 2011-01-21 S Sale Novartis Bioventures Ltd Large shareholder
300 -0.0%
1.29
US$387 		300 -0.0% 1.29 US$387
2011-01-25 2011-01-21 S Sale Novartis Bioventures Ltd Large shareholder
900 -0.0%
1.28
US$1,152 		900 -0.0% 1.28 US$1,152
2011-01-25 2011-01-21 S Sale Novartis Bioventures Ltd Large shareholder
5,935 -0.2%
1.27
US$7,537 		5,935 -0.2% 1.27 US$7,537
2011-01-25 2011-01-21 S Sale Novartis Bioventures Ltd Large shareholder
22,865 -0.8%
1.26
US$28,810 		22,865 -0.8% 1.26 US$28,810
2011-01-25 2011-01-21 S Sale Novartis Bioventures Ltd Large shareholder
34,200 -1.2%
1.25
US$42,750 		34,200 -1.2% 1.25 US$42,750
2011-01-25 2011-01-21 S Sale Novartis Bioventures Ltd Large shareholder
4,900 -0.2%
1.24
US$6,076 		4,900 -0.2% 1.24 US$6,076
2011-01-25 2011-01-21 S Sale Novartis Bioventures Ltd Large shareholder
200 -0.0%
1.23
US$246 		200 -0.0% 1.23 US$246
2011-01-21 2011-01-20 S Sale Novartis Bioventures Ltd Large shareholder
1,000 -0.0%
1.50
US$1,500 		1,000 -0.0% 1.50 US$1,500
2011-01-21 2011-01-20 S Sale Novartis Bioventures Ltd Large shareholder
100 -0.0%
1.49
US$149 		100 -0.0% 1.49 US$149
2011-01-21 2011-01-20 S Sale Novartis Bioventures Ltd Large shareholder
4,500 -0.2%
1.46
US$6,570 		4,500 -0.2% 1.46 US$6,570
2011-01-21 2011-01-20 S Sale Novartis Bioventures Ltd Large shareholder
4,400 -0.2%
1.43
US$6,292 		4,400 -0.2% 1.43 US$6,292
2011-01-21 2011-01-20 S Sale Novartis Bioventures Ltd Large shareholder
2,800 -0.1%
1.42
US$3,976 		2,800 -0.1% 1.42 US$3,976
2011-01-21 2011-01-20 S Sale Novartis Bioventures Ltd Large shareholder
1,500 -0.1%
1.41
US$2,115 		1,500 -0.1% 1.41 US$2,115
2011-01-21 2011-01-20 S Sale Novartis Bioventures Ltd Large shareholder
5,200 -0.2%
1.40
US$7,280 		5,200 -0.2% 1.40 US$7,280
2011-01-21 2011-01-20 S Sale Novartis Bioventures Ltd Large shareholder
4,500 -0.2%
1.39
US$6,255 		4,500 -0.2% 1.39 US$6,255
2011-01-21 2011-01-20 S Sale Novartis Bioventures Ltd Large shareholder
6,292 -0.2%
1.38
US$8,683 		6,292 -0.2% 1.38 US$8,683
2011-01-21 2011-01-20 S Sale Novartis Bioventures Ltd Large shareholder
208 -0.0%
1.37
US$285 		208 -0.0% 1.37 US$285
2011-01-21 2011-01-20 S Sale Novartis Bioventures Ltd Large shareholder
2,700 -0.1%
1.35
US$3,645 		2,700 -0.1% 1.35 US$3,645
2011-01-21 2011-01-20 S Sale Novartis Bioventures Ltd Large shareholder
2,057 -0.1%
1.33
US$2,736 		2,057 -0.1% 1.33 US$2,736
2011-01-21 2011-01-20 S Sale Novartis Bioventures Ltd Large shareholder
1,943 -0.1%
1.32
US$2,565 		1,943 -0.1% 1.32 US$2,565
2011-01-21 2011-01-20 S Sale Novartis Bioventures Ltd Large shareholder
2,500 -0.1%
1.31
US$3,275 		2,500 -0.1% 1.31 US$3,275
2011-01-21 2011-01-20 S Sale Novartis Bioventures Ltd Large shareholder
2,000 -0.1%
1.30
US$2,600 		2,000 -0.1% 1.30 US$2,600
2011-01-21 2011-01-20 S Sale Novartis Bioventures Ltd Large shareholder
200 -0.0%
1.29
US$258 		200 -0.0% 1.29 US$258
2011-01-21 2011-01-20 S Sale Novartis Bioventures Ltd Large shareholder
1,000 -0.0%
1.27
US$1,270 		1,000 -0.0% 1.27 US$1,270
Explore more

More insider trading research around Adhera Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America